Balance Sheet
Cash Flow Statement
Cash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmatrix (PULM) Change in Accured Expenses (2016 - 2025)

Pulmatrix's Change in Accured Expenses history spans 13 years, with the latest figure at -$123000.0 for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 26.8% year-over-year to -$123000.0; the TTM value through Dec 2025 reached -$63000.0, up 85.62%, while the annual FY2025 figure was -$63000.0, 85.62% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$123000.0 at Pulmatrix, down from $16000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $1.1 million in Q3 2022 and bottomed at -$1.6 million in Q3 2024.
  • The 5-year median for Change in Accured Expenses is -$89500.0 (2024), against an average of -$98550.0.
  • The largest annual shift saw Change in Accured Expenses crashed 630.26% in 2022 before it skyrocketed 3545.83% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at -$152000.0 in 2021, then plummeted by 630.26% to -$1.1 million in 2022, then fell by 18.29% to -$1.3 million in 2023, then surged by 92.61% to -$97000.0 in 2024, then decreased by 26.8% to -$123000.0 in 2025.
  • Per Business Quant, the three most recent readings for PULM's Change in Accured Expenses are -$123000.0 (Q4 2025), $16000.0 (Q3 2025), and -$82000.0 (Q2 2025).